CYGB and Hepatic fibrosis: This study demonstrated that AHCC inhibited HSCs activation by inducing cytoglobin through the TLR2-SAPK/JNK pathway and suppressing collagen production via the TLR4-NF-κβ pathway, resulting in the prevention of liver fibrosis progression.